Richard W. Tseng is an accomplished inventor based in Mission Viejo, CA. He holds 2 patents that contribute significantly to the field of genetic testing. His work focuses on developing high-throughput assays for detecting specific gene rearrangements, which are crucial for monitoring therapeutic responses in patients.

Latest Patents

One of his notable patents is an assay for BCR/ABL gene rearrangement. This invention provides a simple high-throughput assay for detecting bcr/abl translocations. The method includes qualitative PCR techniques for identifying the specific amplified translocation (e1a2 or b2a3/b3a2) and real-time PCR for quantifying the amount of bcr/abl transcript (e1a2, b2a3, and b3a2). The quantitative measurement of bcr/abl transcript, as per the methods of this invention, is useful for monitoring response to therapy.

Career Highlights

Richard W. Tseng is currently associated with Quest Diagnostics Investments, Inc., where he applies his expertise in genetic assays. His contributions to the field have been recognized for their potential impact on patient care and treatment monitoring.

Collaborations

He collaborates with Michael K. Samoszuk, enhancing the research and development efforts within their organization.

Conclusion

Richard W. Tseng's innovative work in genetic testing exemplifies the importance of advancements in medical diagnostics. His patents play a vital role in improving patient outcomes through effective monitoring of therapeutic responses.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]